Electronic cigarettes or vaping can increase quit rates compared to nicotine replacement therapy (NRT) according to an updated Cochrane Library review.
The review included 50 completed studies, involving 12 430 people, of which 26 were randomised controlled trials.
There was moderate‐certainty evidence that quit rates were higher …

A family history of cardio-metabolic diseases in men with erectile dysfunction (ED) is a strong predictor of future major adverse cardiovascular events.
In this US study, researchers looked at data from 4693 men with ED attending an andrology clinic. Family history, cardiovascular health at presentation and …

So far this autumn 85 037 men have used the Prostate Cancer UK (PCUK) prostate cancer risk-checker and 67 199 men have been advised to talk to their GP about the risk of having the disease and the pros and cons of having a PSA …

November – or should we say Movember? – is approaching and the men’s health charity started over 16 years ago is gearing up for another month of frantic fundraising.
Like last year men are being asked to gain sponsorship for Growing a Mo (moustache or facial …

A simpler and easier way of taking eye drops is equally effective and safe as the traditional drop directly in the eye method, according to a recent study published in Optometry and Vision Science.
Some patients find it particularly hard to apply eye drops effectively due …

Black men have different genomic mutations in prostate cancer than White or Asian men and this may underlie differences in incidence and prognosis and help direct treatment more effectively, according to a new study in the New England Journal of Medicine.
To better understand prostate cancer …

Referrals for urological cancers have halved during the COVID-19 pandemic, putting as many as 3500 men with higher-risk cancers at risk of being diagnosed too late to be cured, Prostate Cancer UK (PCUK) has warned.
Urgent referrals are at their lowest levels in 10 years, with …

Angiotensin-converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARBs), do not appear to adversely impact patients with COVID-19, and may in fact be beneficial according to a recent meta-analysis published in Current Atherosclerosis Reports.
Because COVID-19 enters cells via the ACE receptor concern has been raised …

A large 10-year UK study of men with localised prostate cancer has shown no significant difference between active monitoring, radical prostatectomy and radical radiotherapy – but the active interventions were associated with more side-effects. 
In the study carried out between 2001 and 2009, 82 429 men …

For men with prostate cancer, initiation of radiotherapy (RT) up to six months after androgen deprivation therapy (ADT) is not associated with worse overall survival, according to a research letter published JAMA Oncology.
The researchers found that among men with unfavourable intermediate-risk cancer, the 10-year overall …